We are live on ! Find out more
VAM

Veritas Asset Management Portfolio holdings

AUM $5.9B
1-Year Est. Return 3.19%
This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
-3.19%
3 Year Est. Return
+26.61%
5 Year Est. Return
+23.16%
10 Year Est. Return
+201.18%
AUM
$11.1B
AUM Growth
+$1.68B
Cap. Flow
+$862M
Cap. Flow %
7.78%
Top 10 Hldgs %
71.6%
Holding
32
New
4
Increased
16
Reduced
4
Closed
4

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$742M
2
TMO icon
Thermo Fisher Scientific
TMO
+$175M
3
CERN
Cerner Corp
CERN
+$171M
4
CVS icon
CVS Health
CVS
+$43.7M
5
CMCSA icon
Comcast
CMCSA
+$43.6M

Top Sells

Rank Stock Value
1
HAL icon
Halliburton
HAL
+$412M
2
VAR
Varian Medical Systems, Inc.
VAR
+$184M
3
SLB icon
SLB Ltd
SLB
+$30.5M
4
PFE icon
Pfizer
PFE
+$10.8M
5
NTES icon
NetEase
NTES
+$10.4M

Sector Composition

Rank Sector Weight
1 Healthcare 37.35%
2 Communication Services 31%
3 Technology 18.65%
4 Financials 6.51%
5 Real Estate 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHTR icon
1
Charter Communications
CHTR
$16.2B
$1.17B 10.58%
3,581,436
+95,514
+3% +$30.4M
CMCSA icon
2
Comcast
CMCSA
$85B
$1.09B 9.83%
28,984,560
+1,174,586
+4% +$43.6M
UNH icon
3
UnitedHealth
UNH
$387B
$802M 7.24%
4,891,989
+191,000
+4% +$31.3M
TSM icon
4
TSMC
TSM
$2.07T
$763M 6.88%
23,219,882
+528,300
+2% +$16.5M
AGN
5
DELISTED
Allergan plc
AGN
$761M 6.87%
+3,186,586
New +$742M
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$4.23T
$740M 6.68%
17,465,660
+666,000
+4% +$28M
AXP icon
7
American Express
AXP
$242B
$708M 6.39%
8,944,727
+344,300
+4% +$26.9M
ORCL icon
8
Oracle
ORCL
$364B
$678M 6.12%
15,201,450
+662,412
+5% +$27.6M
MSFT icon
9
Microsoft
MSFT
$2.93T
$625M 5.64%
9,492,366
+166,100
+2% +$10.6M
CVS icon
10
CVS Health
CVS
$137B
$594M 5.36%
7,572,808
+546,800
+8% +$43.7M
BAX icon
11
Baxter International
BAX
$11.7B
$516M 4.66%
9,951,759
+334,700
+3% +$16.5M
ESRX
12
DELISTED
Express Scripts Holding Company
ESRX
$477M 4.31%
7,240,323
+551,100
+8% +$37.9M
BIDU icon
13
Baidu
BIDU
$36.5B
$428M 3.87%
2,483,611
+175,900
+8% +$31M
XRAY icon
14
Dentsply Sirona
XRAY
$2.81B
$377M 3.41%
6,043,539
+287,800
+5% +$17.3M
WAT icon
15
Waters Corp
WAT
$36.2B
$377M 3.41%
2,413,863
-55,471
-2% -$8.28M
CERN
16
DELISTED
Cerner Corp
CERN
$187M 1.69%
+3,172,900
New +$171M
TMO icon
17
Thermo Fisher Scientific
TMO
$198B
$176M 1.59%
+1,144,500
New +$175M
WELL icon
18
Welltower
WELL
$172B
$56.2M 0.51%
793,000
– –
PFE icon
19
Pfizer
PFE
$143B
$54.5M 0.49%
1,679,444
-342,971
-17% -$10.8M
SRCLP
20
DELISTED
Stericycle, Inc
SRCLP
$53.1M 0.48%
742,000
+127,000
+21% +$8.7M
MCO icon
21
Moody's
MCO
$89.2B
$13.8M 0.12%
123,200
– –
BABA icon
22
Alibaba
BABA
$276B
$5.39M 0.05%
50,000
-50,000
-50% -$5.09M
GOOG icon
23
Alphabet (Google) Class C
GOOG
$4.22T
$4.85M 0.04%
116,960
-18,320
-14% -$751K
FNV icon
24
Franco-Nevada
FNV
$38.7B
$4M 0.04%
61,000
+24,500
+67% +$1.58M
SHPG
25
DELISTED
Shire pic
SHPG
$2.55M 0.02%
14,612
– –
1
2

Similar funds

TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $5.92B AUM 23.78% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $5.87B AUM 24.95% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Veritas Asset Management's Q1 2017 Portfolio in Review

As of Q1 2017, Veritas Asset Management held 32 positions worth $11.1B, up 18% from $9.4B the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Veritas Asset Management deployed $862M of net new capital in Q1 2017, opening 4 new positions and adding to 16 existing holdings. Its largest new stake was Allergan plc: 3,186,586 shares worth $761M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 31% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Pfizer, an estimated $10.8M trimmed.

  • Veritas Asset Management's largest Q1 2017 buy was Allergan plc: 3,186,586 shares worth $761M.
  • Veritas Asset Management added most to CVS Health in Q1 2017, an estimated $43.7M increase.
  • Veritas Asset Management's biggest Q1 2017 reduction was Pfizer, cutting an estimated $10.8M.
  • Veritas Asset Management fully exited Halliburton in Q1 2017, selling an estimated $412M.
  • Veritas Asset Management's ten largest holdings make up 72% of its $11.1B portfolio in Q1 2017.
  • Veritas Asset Management opened 4 new positions and closed 4 in Q1 2017.
  • Veritas Asset Management's portfolio value rose 18% quarter-over-quarter to $11.1B.

Based on Veritas Asset Management's 13F filing for Q1 2017, filed 11 May 2017.